May 2016

Update: cCMV Nomination for the Recommended Uniform Screening Panel (RUSP)

The most recent update about our nomination for congenital CMV (cCMV) for inclusion on the Recommended Uniform Screening Panel (RUSP) by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) by Megan Pesch, MD, MS, FAAP, President-Elect National CMV Foundation. 

Acquired CMV: Risks and Treatments

Acquired CMV infection is when a person is infected with CMV after birth, whether during childhood or adulthood. Acquired CMV is actually very common with anywhere from 50-80% of adults in the United States having been infected with CMV by the time they reach 40 years old. However, acquired CMV can cause serious problems for people who are immunocompromised and those who have weakened immune systems.

Acquired CMV: Intro and Symptoms

If you have been affected by congenital CMV, it’s very possible that someone else in your life has also been affected by CMV, but in a very different way. It could be your grandmother who suffered from CMV complications during chemotherapy treatment to fight cancer. Or maybe a family friend who contracted CMV after a successful transplant surgery.